
Meeting Resources
ESMO Calendar Abstracts Supplements from Annals of Oncology and ESMO Open | Unpublished past meetings
Featured


ESMO Webinars
Access our on-demand webinar series featuring the world’s top oncology experts.
On-demand CME:
- Up to 2 ESMO-MORA category 1 points available per webinar.
- CME certificate available
- May contribute to the ESMO Certificate of Professional Development

Education Library
ESMO online educational resources are regularly reviewed and updated by oncology experts.
120 meetings available
Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Final overall survival (OS) from the phase III TROPION-Breast01 trial
Chair: Peter Schmid, UK; Presenter: Barbara Pistilli, France; Discussant: Veronique Dieras, France; AACR Expert Commentary: Sarat Chandarlapaty, USA